New treatment welcome news for Parkinson's and stroke patients

July 11, 2012

(Medical Xpress) -- New research developed by The University of Queensland is set to change the future treatment of speech problems associated with stroke and Parkinson's disease.

The new treatment is promising news for people with speech and language disorders that result from diseases within the .

Professor Bruce Murdoch of the Centre for Neurogenic Communication Disorders Research within UQ's School of Health and said preliminary trials of the new treatment were positive in the effective treatment of these speech and language disorders.

The research has found a , transcranial (TMS), can be used to stimulate the brain with a series of delivered by a stimulating coil held over selected areas of the head.

Professor Murdoch said TMS featured a coil, shaped like a figure eight, that was held over the patient's head to “switch on part of the brain” in Parkinson's sufferers and “switch off” a different part in stroke victims.

“The non-invasive technology is proving very effective in treating long-term sufferers of stroke and Parkinson's disease, where traditional therapy approaches have proven ineffective,” he said.

“The brain can heal itself much better than we thought it could.

“Based on these findings, TMS would appear to have the potential to revolutionise the treatment of brain-based speech and language disorders with improved outcomes and quality of life for sufferers of neurological disease.”

Professor Murdoch said the trials have recorded positive results within a week to two months after treatment, with patients still recording improvement 12 months' post-stimulation.

“When present, these disorders have a serious impact on quality of life, often leading to an inability to communicate with family and friends, social isolation, loss of vocational standing and financial hardship,” he said.

“Unfortunately speech and language disorders associated with conditions such as stroke and Parkinson's disease have proven difficult to treat, and consequently many sufferers of these conditions experience long-term impairment of their ability to speak and communicate with others.”

Professor Murdoch, in collaboration with colleagues from the University of Hong Kong, is extending the research to include investigation of the use of TMS in the treatment of swallowing disorders post-, as well as its potential application in the treatment of brain-based voice problems.

Explore further: Magnetic treatment improves stroke patients' ability to communicate

Related Stories

Magnetic treatment improves stroke patients' ability to communicate

November 15, 2011
(Medical Xpress) -- Magnetic stimulation of the brain could help improve language skills of stroke survivors with aphasia, according to research by The University of Queensland.

Anti-inflammatory chemical could prevent stroke damage

December 5, 2011
(Medical Xpress) -- Drugs that block inflammation in the brain could help patients who have a stroke or a brain haemorrhage, Manchester scientists said today (5 December) at the British Society for Immunology Congress in ...

Research holds out hope for stroke patients

May 21, 2012
(Medical Xpress) -- People with a curious condition that causes them to apply make-up on only one side of their face, or ignore food on half of their plate, are playing a new role in understanding stroke recovery.

Recommended for you

Singing may be good medicine for Parkinson's patients

August 11, 2017
(HealthDay)—Singing? To benefit people with Parkinson's disease? It just may help, a researcher says.

Tracing the path of Parkinson's disease proteins

August 4, 2017
As neurodegenerative disorders such as Parkinson's and Alzheimer's disease progress, misfolded proteins clump together in neurons, recruiting normal proteins in the cell to also misfold and aggregate. Cells in which this ...

Diabetes drug shows potential as disease-modifying therapy for Parkinson's disease

August 3, 2017
A drug commonly used to treat diabetes may have disease-modifying potential to treat Parkinson's disease, a new UCL-led study suggests, paving the way for further research to define its efficacy and safety.

Two new studies offer insights into gastrointestinal dysfunction in Parkinson's patients

July 31, 2017
Constipation is one of the most common non-motor related complaints affecting Parkinson's disease (PD) patients. Two important studies from the same research group published in the Journal of Parkinson's Disease expand the ...

New drug may treat and limit progression of Parkinson's disease

July 31, 2017
Researchers at Binghamton University have developed a new drug that may limit the progression of Parkinson's disease while providing better symptom relief to potentially hundreds of thousands of people with the disease.

A new insight into Parkinson's disease protein

July 28, 2017
Abnormal clumps of certain proteins in the brain are a prominent feature of Parkinson's and other neurodegenerative diseases, but the role those same proteins might play in the normal brain has been unknown.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.